Are you bettwr than gpt in case of medical dr
| Feature | Orris | GPT (standard) |
|---|---|---|
| Textbook library search | Yes (indexed, cited) | No |
| PubMed integration | Yes (live search) | Depends on version/plugins |
| Image retrieval from textbooks | Yes | No |
| Cites specific sources | Yes, with page numbers | Sometimes |
| Up-to-date guidelines | Via PubMed | Via web browsing (GPT-4o) |
Premature ejaculation and it’s all treatment step by step
"premature ejaculation" treatment
| Type | Description |
|---|---|
| Lifelong (Primary) PE | Present from first sexual encounter; ejaculation in <1-2 min; neurobiologic basis |
| Acquired (Secondary) PE | Develops after a period of normal ejaculation; often situational; linked to ED, anxiety, thyroid disease |
| Variable PE | Occasional early ejaculation; considered a natural variation, NOT a disorder |
| Subjective PE | Patient complains of PE but has normal latency (2-6 min); psychological/cultural basis |
Note: Psychosexual CBT (Cognitive Behavioral Therapy) has a limited role as first-line monotherapy but plays a key role as an adjunct to pharmacotherapy, especially in acquired PE. - Campbell-Walsh Urology, p. 2087
| Drug | Dose | IELT Fold-Increase |
|---|---|---|
| Paroxetine | 10-40 mg/day | Greatest efficacy (~8-12 fold) |
| Sertraline | 50-200 mg/day | Moderate |
| Fluoxetine | 20-40 mg/day | Moderate |
| Clomipramine (TCA) | 12.5-50 mg/day | Moderate |
"Psychosexual CBT has a limited role as a first-line treatment for PE but has an important role as an adjunct to pharmacotherapy." - Campbell-Walsh Urology, p. 2087
Step 1: Psychosexual/behavioral techniques (stop-start, squeeze, sensate focus)
↓ (if insufficient)
Step 2: Topical anesthetics (EMLA cream, lidocaine spray)
↓ (if insufficient)
Step 3: Oral pharmacotherapy
- On-demand: Dapoxetine 30-60mg OR Tramadol 50mg
- Daily: Paroxetine > Sertraline/Fluoxetine/Clomipramine
↓ (treat underlying cause if acquired PE)
Step 4: Treat ED (PDE5i), hyperthyroidism, prostatitis as appropriate
↓ (refractory cases)
Step 5: Surgical options (dorsal neurectomy, botulinum toxin, hyaluronic acid) - specialist only
Okay if its primary pe
"lifelong premature ejaculation" treatment SSRIs
"Men with L-PE are best managed with PE pharmacotherapy" - Campbell-Walsh Urology, p. 2083

Clinical tip: Try each drug for at least 4-6 weeks at adequate dose before declaring failure and switching.
| Scenario | Action |
|---|---|
| Good response | Consider gradual drug withdrawal to see if sustained; if relapse, restart long-term |
| Partial response | Increase SSRI dose OR add topical agent OR switch to combination |
| No response to one SSRI | Switch to another SSRI (response to paroxetine vs sertraline can differ) |
| SSRI side effects intolerable | Switch to dapoxetine (on-demand) or clomipramine |
STEP 1: Confirm diagnosis (lifelong, from first encounter, with all partners)
STEP 2: Educate patient + involve partner
STEP 3: Daily SSRI → Paroxetine (first choice) or Sertraline/Fluoxetine
STEP 4: If daily drugs refused → Dapoxetine on-demand
STEP 5: Add topical anesthetic (EMLA or lidocaine spray) for extra effect
STEP 6: Add behavioral therapy (stop-start / squeeze) as adjunct
STEP 7: Review at 6-8 weeks → dose-adjust or switch if needed
STEP 8: Tramadol if SSRIs completely contraindicated (use cautiously)
STEP 9: Long-term plan - most patients need continued treatment
Bottom line for primary PE: Pharmacotherapy (SSRI) is the cornerstone - not behavioral therapy alone. Behavioral therapy is helpful as an add-on but cannot correct the underlying neurobiologic deficit by itself.
In general in how many months or years the patient improves without need of medication anymore
"premature ejaculation" long-term outcome drug discontinuation remission
"premature ejaculation" SSRI withdrawal recurrence
lifelong primary premature ejaculation spontaneous remission without medication prognosis
"Lifelong premature ejaculation has no definitive cure. In many cases, pharmacological therapy must be continued indefinitely, as discontinuation may lead to the recurrence of premature ejaculation."
In a clinical series of 32 men on paroxetine 20 mg/day for 2 months:
- 28 out of 32 patients (87.5%) had PE recurrence within 2-3 weeks after stopping therapy
- AUA Pharmacologic Management of PE Guidelines
| Scenario | What to Expect |
|---|---|
| On daily SSRI | Good control within 1-4 weeks; maintained as long as drug is taken |
| Stop drug after 6-8 weeks | ~87% relapse within 2-3 weeks |
| Long-term behavioral therapy alone | Modest sustained improvement possible, but rarely drug-free "cure" for lifelong PE |
| Combination drug + behavioral therapy | Best chance of sustained improvement; a 2025 meta-analysis (PMID: 41020367) shows this combination gives superior long-term outcomes vs drugs alone |
| Acquired PE (not primary) | Much better - treating the cause (ED, thyroid, prostatitis) can fully resolve it |
| Type | Drug-free remission? |
|---|---|
| Primary/Lifelong PE | Unlikely - most need long-term or indefinite pharmacotherapy. Behavioral skills can help but rarely eliminate the need for drugs entirely |
| Acquired/Secondary PE | Yes - once the underlying cause is treated, many men no longer need PE-specific medication |
How much chances the conditions will Improve on medication?
"premature ejaculation" SSRI dapoxetine efficacy IELT improvement
PMID: 40326158
premature ejaculation medication success rate percentage patients improve SSRI dapoxetine clinical data
| Drug | Average IELT Increase vs Baseline | vs Placebo |
|---|---|---|
| Paroxetine (daily) | +5.64 minutes (best of all drugs) | Most effective overall |
| Dapoxetine 60 mg | +2.7 minutes from baseline | ~3x fold increase |
| Dapoxetine 30 mg | +2.3 minutes from baseline | ~2.5x fold increase |
| Topical anesthetics | Significant increase | 5-6x fold |
| Tramadol | +2.49 minutes | ~2.5x fold |
A man ejaculating in 30-45 seconds could go to 3-6 minutes on paroxetine. That is a transformative change for most patients.
| Outcome | Placebo | Dapoxetine 30mg | Dapoxetine 60mg |
|---|---|---|---|
| PE rated "better" or "much better" | 13.9% | 30.7% | 38.3% |
| PE rated "at least slightly better" | 36.0% | 62.1% | 71.7% |
| Partners satisfied ("good"/"very good") | 24.0% | 37.5% | 44.7% |
64.2% of patients achieved the predefined therapeutic threshold of meaningful IELT improvement
- Mean IELT increased by +1.63 minutes from baseline
- Consistent across all age groups and BMI categories
| Outcome | Placebo | Dapoxetine 30mg | Dapoxetine 60mg |
|---|---|---|---|
| "Quite a bit / extreme" personal distress | 39% | 28.2% | 22.2% |
| Interpersonal difficulty | 23.8% | 16.0% | 12.3% |
| Timepoint | % who stopped taking dapoxetine |
|---|---|
| 1 month | 26.4% |
| 3 months | 61.6% |
| 6 months | 79.1% |
| 12 months | 87.3% |
| 24 months | 90.1% |
| Question | Answer |
|---|---|
| Will my ejaculation time increase? | Yes - almost certainly. Most men get 2-6x improvement in IELT |
| Will I feel better overall? | ~60-70% yes - at least partial improvement |
| Will I feel "much better"? | ~30-40% report marked improvement |
| Will my distress and anxiety reduce? | Yes - significant reduction in personal and relationship distress |
| Is paroxetine or dapoxetine better? | Paroxetine gives the largest IELT increase (+5.64 min) but requires daily dosing; dapoxetine is on-demand and more convenient |
| Combination (drug + topical + therapy)? | Best overall results - additive effects |
Bottom line: Medication has a high chance of meaningful improvement in ejaculation time and quality of life. The key is setting the right expectation - it controls PE very well, but it is a management tool, not a permanent cure for primary PE.